AAP
DSCI

Ardsley Advisory Partners’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Ardsley Advisory Partners’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-20,000
Closed -$231K – 320
2014
Q2 		$231K Sell
20,000
-250,000
-93% -$2.57M 0.03% 216
2014
Q1 		$3.42M Buy
+270,000
New +$3.49M 0.51% 41

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Ardsley Advisory Partners's DSCI Position: Q3 2014 in Review

Ardsley Advisory Partners sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2014, closing a stake of 20,000 shares — an estimated $231K sold.

Ardsley Advisory Partners first reported a position in DSCI in Q1 2014 and held it in 2 quarters. The position peaked at $3.42M in Q1 2014. 70 funds tracked by Wall St. Rank hold DSCI as of Q3 2014.

  • Ardsley Advisory Partners reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2014 after selling out during the quarter.
  • Ardsley Advisory Partners sold 20,000 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2014, an estimated $231K.
  • Ardsley Advisory Partners first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q1 2014 and held it in 2 quarters.
  • Ardsley Advisory Partners's Derma Sciences, Inc. Common Stock (DE) position peaked at $3.42M in Q1 2014.
  • 70 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2014.

Based on Ardsley Advisory Partners's 13F filing for Q3 2014, filed 13 Nov 2014.